Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 20, 2010, to report its financial results for the second quarter ended June 30, 2010. The filing primarily serves to attach a press release detailing these results, which includes both GAAP and non-GAAP financial measures. Management believes these non-GAAP metrics offer additional insight into the company's operational performance and are used internally for planning and budgeting. Investors should note that this 8-K is an informational filing and the presented information is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act. The primary value for investors lies within the accompanying press release (Exhibit 99.1), which contains the detailed financial data and management's commentary on the quarter's performance. A reconciliation between GAAP and non-GAAP figures is provided in the press release.
Key Highlights
- 1Gilead Sciences announced its financial results for the second quarter ended June 30, 2010.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing the detailed financial results.
- 3The company presented financial information using both Generally Accepted Accounting Principles (GAAP) and non-GAAP measures.
- 4Management indicated that non-GAAP information is useful for investors and is used internally for operational and financial planning.
- 5A reconciliation between GAAP and non-GAAP financial data is available in the press release.
- 6The filing does not include new material agreements or executive changes, focusing solely on financial reporting.
- 7The information furnished in this 8-K is not deemed 'filed' for specific legal liabilities under Section 18 of the Exchange Act.